2-Methyl-8-(pyridin-2-yl)benzofuro[2,3-b]pyridine
CAS: 1609373-99-0
Category: Organic Pharmaceutical Intermediates
| Purity | ≥97.0% (HPLC); ≥98.0% (HPLC); ≥99.0% (HPLC) |
| Molecular Formula | C17H12N2O |
| Molecular Weight | 260.29 |
| Appearance | Off-white to pale yellow crystalline powder |
| Packaging | 100 mg, 250 mg, 1 g, 5 g, 10 g, 25 g, or 100 g amber glass bottle or aluminum foil bag with moisture-proof inner liner |
| Testing Indicators | Appearance — Visual inspection; Identification — LC-MS, HRMS, FTIR, 1H NMR and 13C NMR; Assay/Purity — HPLC (UV); Related substances — HPLC; Water content — Karl Fischer titration (USP <921>); Residual solvents — GC (USP <467>); Melting point — USP <741>; Elemental impurities — ICP-MS/ICP-OES; Structure confirmation — High-resolution mass spectrometry and multidimensional NMR spectroscopy. |
| Storage Notes | Store tightly sealed in a cool, dry, well-ventilated location. Protect from moisture, excessive heat, and direct sunlight. Long-term storage at 2–8°C under an inert atmosphere (nitrogen or argon) is recommended to maintain product quality. |
| Lead Time | 10 days |
An advanced fused heteroaryl intermediate used in medicinal chemistry and pharmaceutical research. Widely employed in the synthesis of kinase inhibitors, GPCR ligands, oncology drug candidates, heterocyclic pharmaceutical intermediates, OLED materials, and other functional π-conjugated organic compounds.